Patent intelligence · US
US 8920848
Use of cellular extracts for skin rejuvenation
Use of cellular extracts for skin rejuvenation
Patent details — US 8920848
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 30, 2014
- Expiration
- Dec 25, 2034
- Applicant
- REGENICS AS
- Claims
- 20
- CPC classes
- A61K, A61K35/60, A61K8/676, A61K8/982
Quick answer
US 8920848 (Use of cellular extracts for skin rejuvenation) is held by REGENICS AS. Status: granted. Granted Dec 30, 2014. Expires Dec 25, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- REGENICS AS
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K35/60, A61K8/676, A61K8/982, A61K8/987
More from REGENICS AS
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 8920848?
US 8920848 (Use of cellular extracts for skin rejuvenation) is held by REGENICS AS. Status: granted. Granted Dec 30, 2014. Expires Dec 25, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8920848?
REGENICS AS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 8920848 expire?
Our index shows an expiration date of Dec 25, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.